Childhood-onset nemaline myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:171439OMIM:161800G71.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Childhood-onset nemaline myopathy (also called childhood-onset NM or typical nemaline myopathy) is a rare inherited neuromuscular disorder characterized by progressive or nonprogressive muscle weakness that becomes apparent during childhood, typically between 1 and 10 years of age. It belongs to the broader group of nemaline myopathies, which are defined by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to generalized muscle weakness that is often more prominent in proximal muscles (those closer to the trunk), facial muscles, and the muscles of the neck and limbs. Affected children may present with delayed motor milestones, difficulty running or climbing stairs, facial weakness with an elongated face, a high-arched palate, nasal speech, and reduced muscle bulk. Respiratory muscles can also be involved, potentially leading to respiratory insufficiency that may require ventilatory support. The childhood-onset form is generally considered to have a more favorable prognosis compared to the severe congenital form of nemaline myopathy, though the clinical course is variable. Some patients remain relatively stable, while others experience slow progression of weakness over time. Skeletal complications such as scoliosis, foot deformities, and joint contractures may develop. Cardiac involvement is uncommon but has been reported in rare cases. Nemaline myopathy can be caused by pathogenic variants in several genes encoding components of the thin filament of the sarcomere, including NEB (nebulin), ACTA1 (skeletal muscle alpha-actin), TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, and LMOD3, among others. There is currently no cure or disease-specific treatment for childhood-onset nemaline myopathy. Management is supportive and multidisciplinary, including physical therapy to maintain mobility and prevent contractures, respiratory monitoring and support when needed, orthopedic interventions for skeletal deformities, and speech therapy for feeding or swallowing difficulties.

Also known as:

Clinical phenotype terms— hover any for plain English:

Facial diplegiaHP:0001349Slender buildHP:0001533Breech presentationHP:0001623Fetal akinesia sequenceHP:0001989Bulbar signsHP:0002483Reduced vital capacityHP:0002792
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Childhood-onset nemaline myopathy.

View clinical trials →

No actively recruiting trials found for Childhood-onset nemaline myopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Childhood-onset nemaline myopathy community →

No specialists are currently listed for Childhood-onset nemaline myopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Childhood-onset nemaline myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Childhood-onset nemaline myopathyForum →

No community posts yet. Be the first to share your experience with Childhood-onset nemaline myopathy.

Start the conversation →

Latest news about Childhood-onset nemaline myopathy

No recent news articles for Childhood-onset nemaline myopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Childhood-onset nemaline myopathy

What is Childhood-onset nemaline myopathy?

Childhood-onset nemaline myopathy (also called childhood-onset NM or typical nemaline myopathy) is a rare inherited neuromuscular disorder characterized by progressive or nonprogressive muscle weakness that becomes apparent during childhood, typically between 1 and 10 years of age. It belongs to the broader group of nemaline myopathies, which are defined by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to generalized muscle weakness that is often more prominent in proximal muscle

At what age does Childhood-onset nemaline myopathy typically begin?

Typical onset of Childhood-onset nemaline myopathy is childhood. Age of onset can vary across affected individuals.